Stock Symbol 01177
About Us
About Sino Biopharm
Management Team
Major Events
R&D
Products
Innovative Products
Oncology
Hepatology
Respiratory
Surgery/Analgesic
Others
News
Sustainability
ESG Strategy and Governance
ESG Policies and Commitments
ESG Dynamics
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQs
Notices
Legel Terms
Our Culture
Human Development
Join Us
CN
EN
Sustainability
Home
>
Sustainability
>
ESG Dynamics
ESG Strategy and Governance
ESG Policies and Commitments
ESG Dynamics
ESG Reports
Sino Biopharm Integrity Culture Construction
Release Date: 2024-06-03
Share:
Previous：
CCTV's "China ESG Listed Companies Pioneer 100" List Released, Sino Biopharm Selected Again
Next：
Sino Biopharm Released 2023 ESG Report, Comprehensively Advancing CARE Strategy and Steadily Implementing Three-Year Plan
Stock Symbol 01177
Stock Symbol 01177